LABU
Direxion Daily S&P Biotech Bull 3X Shares
Price Chart
Latest Quote
$257.80
+9.76 (+3.93%)
Current Price
| Previous Close | $248.04 |
| Open | $250.24 |
| Day High | $272.45 |
| Day Low | $249.95 |
| Volume | 652,384 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.63% |
| Net Assets | $571.29M |
| Expense Ratio | 0.96% |
| Category | Trading--Leveraged Equity |
| Fund Family | Direxion Funds |
| Net Asset Value | $248.04 |
| Premium/Discount | 3.93% |
| Quarterly Dividend Yield | 0.63% |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $191.28 |
| SMA50 | $188.19 |
| SMA200 | $155.44 |
| RSI | 76.87 |
| ATR | 18.8211 |
| Rel Volume | 0.95 |
Performance History
| Week | +28.64% |
| Month | +42.05% |
| Quarter | +66.43% |
| 6 Months | +46.47% |
| YTD | +63.68% |
| Year | +340.78% |
| 3 Years | +88.30% |
| 5 Years | -81.79% |
| 10 Years | -40.44% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $257.80 | 652,384 |
| 2026-06-24 | $248.04 | 460,500 |
| 2026-06-23 | $235.21 | 560,900 |
| 2026-06-22 | $230.01 | 767,900 |
| 2026-06-18 | $206.86 | 929,900 |
| 2026-06-17 | $200.41 | 1,029,300 |
| 2026-06-16 | $184.63 | 426,800 |
| 2026-06-15 | $188.53 | 505,600 |
| 2026-06-12 | $178.62 | 492,000 |
| 2026-06-11 | $174.49 | 645,500 |
| 2026-06-10 | $160.13 | 655,400 |
| 2026-06-09 | $169.98 | 841,200 |
| 2026-06-08 | $159.15 | 599,300 |
| 2026-06-05 | $160.26 | 730,200 |
| 2026-06-04 | $179.22 | 773,900 |
| 2026-06-03 | $165.45 | 584,100 |
| 2026-06-02 | $158.16 | 1,337,800 |
| 2026-06-01 | $181.67 | 725,800 |
| 2026-05-29 | $195.30 | 516,900 |
| 2026-05-28 | $191.66 | 455,000 |
| 2026-05-27 | $186.00 | 592,000 |
| 2026-05-26 | $181.48 | 359,200 |
About Direxion Daily S&P Biotech Bull 3X Shares
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
📰 Latest News
LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout
24/7 Wall St. • 2026-04-27T19:33:57ZEqual-Weight ETFs Are the Play for Small-Cap Drug Development. Here’s How to Position Now
24/7 Wall St. • 2026-04-23T17:22:32Z
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
24/7 Wall St. • 2026-01-16T13:06:37Z
Best-Performing Leveraged ETFs of October
Zacks • 2025-11-04T12:41:00Z
Leveraged ETF Areas of Last Week That Are Up At least 15%
Zacks • 2025-09-08T12:10:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.